Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Avidity Biosciences, Inc. (RNAM)

Flanagan W. Michael — Chief Scientific Officer
Jan 21, 2026
Sale
Shares
3,976
Price
$72.45
Total Value
$288.06K
Shares Held After
87,651
% of Holdings
4.3%

Avidity Biosciences, Inc. (RNAM)

MacLean Michael F — Chief Financial Officer
Jan 21, 2026
Sale
Shares
2,735
Price
$72.45
Total Value
$198.15K
Shares Held After
59,290
% of Holdings
4.4%

Avidity Biosciences, Inc. (RNAM)

MacLean Michael F — Chief Financial Officer
Jan 21, 2026
Sale
Shares
1,807
Price
$72.45
Total Value
$130.92K
Shares Held After
62,025
% of Holdings
2.8%
Jan 21, 2026
Sale
Shares
1,758
Price
$72.45
Total Value
$127.37K
Shares Held After
16,562
% of Holdings
9.6%

Avidity Biosciences, Inc. (RNAM)

McCarthy Teresa — Chief Human Resources Officer
Jan 21, 2026
Sale
Shares
1,453
Price
$72.45
Total Value
$105.27K
Shares Held After
113,938
% of Holdings
1.3%

Avidity Biosciences, Inc. (RNAM)

McCarthy Teresa — Chief Human Resources Officer
Jan 21, 2026
Sale
Shares
1,476
Price
$72.45
Total Value
$106.94K
Shares Held After
115,391
% of Holdings
1.3%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 21, 2026
Sale
Shares
2,247
Price
$1.81
Total Value
$4.06K
Shares Held After
180,686
% of Holdings
1.2%

Acumen Pharmaceuticals, Inc. (ABOS)

Siemers Eric — Chief Medical Officer
Jan 21, 2026
Sale
Shares
2,331
Price
$1.80
Total Value
$4.20K
Shares Held After
256,266
% of Holdings
0.9%

Acumen Pharmaceuticals, Inc. (ABOS)

Zuga Matt — CFO & Chief Business Officer
Jan 21, 2026
Sale
Shares
2,473
Price
$1.81
Total Value
$4.47K
Shares Held After
306,611
% of Holdings
0.8%
Jan 21, 2026
Sale
Shares
9,346
Price
$1.81
Total Value
$16.93K
Shares Held After
883,964
% of Holdings
1.0%

Acumen Pharmaceuticals, Inc. (ABOS)

Barton Russell — Chief Operating Officer
Jan 21, 2026
Sale
Shares
2,315
Price
$1.81
Total Value
$4.18K
Shares Held After
205,554
% of Holdings
1.1%
Jan 21, 2026
Sale
Shares
200
Price
$21.00
Total Value
$4.20K
Shares Held After
616,685
% of Holdings
0.0%

Axsome Therapeutics, Inc. (AXSM)

Maizel Ari — Chief Commercial Officer
Jan 21, 2026
Sale
Shares
7,500
Price
$184.44
Total Value
$1.38M
Shares Held After
0
% of Holdings
100.0%

GLAUKOS Corp (GKOS)

Gilliam Joseph E — PRESIDENT & COO
Jan 21, 2026
Sale
Shares
4,502
Price
$124.65
Total Value
$561.17K
Shares Held After
92,366
% of Holdings
4.6%
Jan 21, 2026
Sale
Shares
1,590
Price
$235.00
Total Value
$373.65K
Shares Held After
219,150
% of Holdings
0.7%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 21, 2026
Sale
Shares
36,573
Price
$242.67
Total Value
$8.88M
Shares Held After
64,123
% of Holdings
36.3%

Natera, Inc. (NTRA)

Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Jan 21, 2026
Sale
Shares
602
Price
$235.00
Total Value
$141.47K
Shares Held After
100,696
% of Holdings
0.6%

CorMedix Inc. (CRMD)

Dillione Janet — Director
Jan 21, 2026
Sale
Shares
10,000
Price
$6.88
Total Value
$68.80K
Shares Held After
38,473
% of Holdings
20.6%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Jan 21, 2026
Sale
Shares
600
Price
$235.82
Total Value
$141.49K
Shares Held After
264,078
% of Holdings
0.2%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Jan 21, 2026
Sale
Shares
2,470
Price
$234.12
Total Value
$578.27K
Shares Held After
264,678
% of Holdings
0.9%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Jan 21, 2026
Sale
Shares
93
Price
$235.00
Total Value
$21.86K
Shares Held After
267,148
% of Holdings
0.0%

Natera, Inc. (NTRA)

RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Jan 21, 2026
Sale
Shares
438
Price
$235.00
Total Value
$102.93K
Shares Held After
227,033
% of Holdings
0.2%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Jan 21, 2026
Sale
Shares
293
Price
$235.00
Total Value
$68.86K
Shares Held After
144,699
% of Holdings
0.2%

Natera, Inc. (NTRA)

Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Jan 21, 2026
Sale
Shares
339
Price
$235.00
Total Value
$79.67K
Shares Held After
177,252
% of Holdings
0.2%
Jan 21, 2026
Sale
Shares
14,687
Price
$41.68
Total Value
$612.13K
Shares Held After
29,838
% of Holdings
33.0%

Precision BioSciences, Inc. (DTIL)

Scimeca Dario — General Counsel and Secretary
Jan 21, 2026
Sale
Shares
8,854
Price
$4.03
Total Value
$35.68K
Shares Held After
44,715
% of Holdings
16.5%

Precision BioSciences, Inc. (DTIL)

Kelly John Alexander — Chief Financial Officer
Jan 21, 2026
Sale
Shares
15,213
Price
$4.03
Total Value
$61.31K
Shares Held After
106,448
% of Holdings
12.5%

Precision BioSciences, Inc. (DTIL)

SMITH J. JEFFERSON — Chief Research Officer
Jan 21, 2026
Sale
Shares
10,200
Price
$4.03
Total Value
$41.11K
Shares Held After
110,184
% of Holdings
8.5%

Guardant Health, Inc. (GH)

Monroe Terilyn J. — Chief People Officer
Jan 21, 2026
Sale
Shares
3,249
Price
$115.70
Total Value
$375.90K
Shares Held After
20,990
% of Holdings
13.4%

Guardant Health, Inc. (GH)

Monroe Terilyn J. — Chief People Officer
Jan 21, 2026
Sale
Shares
3,619
Price
$113.48
Total Value
$410.68K
Shares Held After
24,239
% of Holdings
13.0%

Guardant Health, Inc. (GH)

Monroe Terilyn J. — Chief People Officer
Jan 21, 2026
Sale
Shares
1,703
Price
$112.34
Total Value
$191.32K
Shares Held After
27,858
% of Holdings
5.8%

NewAmsterdam Pharma Co N.V. (NAMS)

Somaiya Mayur Ian — Chief Financial Officer
Jan 21, 2026
Sale
Shares
24,362
Price
$33.80
Total Value
$823.44K
Shares Held After
58,382
% of Holdings
29.4%

NewAmsterdam Pharma Co N.V. (NAMS)

Somaiya Mayur Ian — Chief Financial Officer
Jan 21, 2026
Sale
Shares
15,422
Price
$33.25
Total Value
$512.78K
Shares Held After
82,744
% of Holdings
15.7%
Jan 21, 2026
Sale
Shares
146
Price
$178.31
Total Value
$26.03K
Shares Held After
9,087
% of Holdings
1.6%

Karyopharm Therapeutics Inc. (KPTI)

Abate Kristin — Chief Accounting Officer
Jan 21, 2026
Sale
Shares
265
Price
$5.96
Total Value
$1.58K
Shares Held After
22,580
% of Holdings
1.2%
Jan 21, 2026
Purchase
Shares
1,500
Price
$1.32
Total Value
$1.98K
Shares Held After
13,733
% of Holdings
10.9%

RenovoRx, Inc. (RNXT)

Agah Ramtin — Director
Jan 21, 2026
Purchase
Shares
10,000
Price
$1.00
Total Value
$9.97K
Shares Held After
798,460
% of Holdings
1.3%

Serina Therapeutics, Inc. (SER)

Moreadith Randall — Chief Scientific Officer
Jan 21, 2026
Sale
Shares
2,000
Price
$3.00
Total Value
$6.00K
Shares Held After
0
% of Holdings
100.0%

Outset Medical, Inc. (OM)

Nash Marc — EVP Operations R&D & Service
Jan 21, 2026
Sale
Shares
980
Price
$4.98
Total Value
$4.88K
Shares Held After
41,805
% of Holdings
2.3%

Outset Medical, Inc. (OM)

Brottem John L. — General Counsel
Jan 21, 2026
Sale
Shares
1,180
Price
$5.01
Total Value
$5.91K
Shares Held After
35,777
% of Holdings
3.2%

Cabaletta Bio, Inc. (CABA)

Chang David J. — Chief Medical Officer
Jan 21, 2026
Purchase
Shares
8,800
Price
$2.26
Total Value
$19.89K
Shares Held After
8,800
% of Holdings
100.0%

Cabaletta Bio, Inc. (CABA)

Binder Gwendolyn — President, Science & Tech.
Jan 21, 2026
Purchase
Shares
11,312
Price
$2.19
Total Value
$24.76K
Shares Held After
31,312
% of Holdings
36.1%
Jan 21, 2026
Purchase
Shares
22,725
Price
$2.21
Total Value
$50.32K
Shares Held After
22,725
% of Holdings
100.0%

Cabaletta Bio, Inc. (CABA)

Gavel Steve — Chief Commercial Officer
Jan 21, 2026
Purchase
Shares
22,170
Price
$2.27
Total Value
$50.22K
Shares Held After
22,170
% of Holdings
100.0%
Jan 21, 2026
Purchase
Shares
4,405
Price
$2.27
Total Value
$9.98K
Shares Held After
5,405
% of Holdings
81.5%
Jan 21, 2026
Sale
Shares
2,120
Price
$5.05
Total Value
$10.71K
Shares Held After
105,703
% of Holdings
2.0%
Jan 21, 2026
Purchase
Shares
45,000
Price
$2.24
Total Value
$100.78K
Shares Held After
1,031,483
% of Holdings
4.4%

Cabaletta Bio, Inc. (CABA)

Simon Mark — Director
Jan 21, 2026
Purchase
Shares
11,061
Price
$2.28
Total Value
$25.26K
Shares Held After
147,205
% of Holdings
7.5%

Cabaletta Bio, Inc. (CABA)

Gerard Michael — General Counsel
Jan 21, 2026
Purchase
Shares
6,600
Price
$2.27
Total Value
$14.98K
Shares Held After
6,600
% of Holdings
100.0%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 21, 2026
Sale
Shares
12,119
Price
$5.05
Total Value
$61.20K
Shares Held After
617,824
% of Holdings
1.9%
Version: v26.3.33